Skip to content

Medical-device intelligence

More Diagnostics: FDA clearances and recalls

Research More Diagnostics in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

16 clearance records and 0 recall records in the covered releases, across 1 source company names and 7 product codes. Dated history runs from Jul 26, 1993 to Jan 30, 2008.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

16 matching records
Device / recordCompany in FDA recordSourceSource date
MYCOPHENOLIC ACID CONTROL, LEVEL 1, 2, 3, 4, 4-LEVELK072257 · LASMore Diagnostics510(k)Jan 30, 2008FDA decision date
RAP/TAC/CSA CONTROL - LEVEL 1,2,3,4K050125 · JJYMore Diagnostics510(k)Mar 18, 2005FDA decision date
CARDIAC MARKERS CONTROL (SINGLE USE)-LEVELS, 1,2,3, MODELS NUMBER 175-1, 175-2, 175-3K982845 · JJTMore Diagnostics510(k)Aug 21, 1998FDA decision date
IMMUNOSUPPRESSANT (WHOLE BLOOD) CONTROL, LEVEL 1 250-1, IMMUNOSUPPRESSANT (WHOLE BLOOS) CONTROL, LEVEL 2, 250-2, IMMUN\SK980331 · DIFMore Diagnostics510(k)Mar 16, 1998FDA decision date
CARDIAC MARKERS CONTROL - LEVEL 1, LEVEL 2, LEVEL 3, TRI-LEVELK972976 · JJTMore Diagnostics510(k)Aug 29, 1997FDA decision date
LEAD CONTROL (WHOLE BLOOD) LEVELS 1,2,3,4K970778 · JJXMore Diagnostics510(k)Apr 17, 1997FDA decision date
FIBRINOGEN CONTROL (HUMAN) LEVEL 1, 2, 3K946193 · GILMore Diagnostics510(k)Aug 24, 1995FDA decision date
MULTI-LEVEL CONTROL FOR FIBRIN DEGRADATION PRODUCTSK943571 · DAPMore Diagnostics510(k)Jun 15, 1995FDA decision date
SERUM BILIRUBIN CONTROL- LEVEL 1, 2 AND 3K944999 · JJXMore Diagnostics510(k)Jun 6, 1995FDA decision date
SERUM VOLATILES CONTROL - LEVELS 1 AND 2K941698 · JJYMore Diagnostics510(k)Jul 28, 1994FDA decision date
WHOLE BLOOD VOLATILES CONTROL, LEVELS 1 AND 2K941876 · JJYMore Diagnostics510(k)Jul 28, 1994FDA decision date
FIBRIN(OGEN) FDP CONTROL LEVEL 1 & LEVEL 2K932657 · DAPMore Diagnostics510(k)Nov 2, 1993FDA decision date
LD-1 ISOENZYME CONTROL (HUMAN) LEVEL 1 & 2K932660 · JJXMore Diagnostics510(k)Oct 28, 1993FDA decision date
CKMB ISOENZYME CONTROL(HUMAN) LEVEL 1,2,& 3K932658 · JJXMore Diagnostics510(k)Jul 28, 1993FDA decision date
MULTI LEVEL CONTROL FOR CKMB ISOENSYME IN SYRUMK932659 · JJXMore Diagnostics510(k)Jul 28, 1993FDA decision date
CYCLOSPORINE (WHOLE BLOOD) CONTROL-PEDIATRIC LEVELK932662 · LASMore Diagnostics510(k)Jul 26, 1993FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗